ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 137 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 8.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $649 | +18.6% | 69 | +40.8% | 0.00% | – |
Q3 2023 | $547 | -95.5% | 49 | -91.3% | 0.00% | -100.0% |
Q2 2023 | $12,048 | +185.0% | 563 | +436.2% | 0.00% | +300.0% |
Q1 2023 | $4,227 | -18.9% | 105 | -6.2% | 0.00% | -50.0% |
Q4 2022 | $5,210 | -25.6% | 112 | -21.7% | 0.00% | -33.3% |
Q3 2022 | $7,000 | +40.0% | 143 | +37.5% | 0.00% | +50.0% |
Q2 2022 | $5,000 | -28.6% | 104 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $7,000 | -36.4% | 104 | -28.3% | 0.00% | -50.0% |
Q4 2021 | $11,000 | +37.5% | 145 | 0.0% | 0.00% | +33.3% |
Q3 2021 | $8,000 | +166.7% | 145 | +137.7% | 0.00% | +200.0% |
Q2 2021 | $3,000 | 0.0% | 61 | +7.0% | 0.00% | 0.0% |
Q1 2021 | $3,000 | +200.0% | 57 | +147.8% | 0.00% | 0.0% |
Q1 2020 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | -91.7% | 23 | -67.1% | 0.00% | -100.0% |
Q1 2019 | $12,000 | +140.0% | 70 | -15.7% | 0.00% | +50.0% |
Q4 2018 | $5,000 | -28.6% | 83 | 0.0% | 0.00% | -33.3% |
Q3 2018 | $7,000 | -22.2% | 83 | 0.0% | 0.00% | -25.0% |
Q2 2018 | $9,000 | +50.0% | 83 | 0.0% | 0.00% | +100.0% |
Q1 2018 | $6,000 | +50.0% | 83 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $4,000 | +33.3% | 83 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $3,000 | -40.0% | 83 | -47.8% | 0.00% | -33.3% |
Q2 2017 | $5,000 | 0.0% | 159 | -6.5% | 0.00% | 0.0% |
Q1 2017 | $5,000 | 0.0% | 170 | -1.7% | 0.00% | 0.0% |
Q4 2016 | $5,000 | +25.0% | 173 | 0.0% | 0.00% | +50.0% |
Q3 2016 | $4,000 | – | 173 | +981.2% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 16 | -89.6% | 0.00% | -100.0% |
Q1 2016 | $4,000 | +300.0% | 154 | +294.9% | 0.00% | +100.0% |
Q4 2015 | $1,000 | – | 39 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 936,777 | $53,218,000 | 16.69% |
Fairmount Funds Management LLC | 316,952 | $18,006,000 | 6.55% |
ARMISTICE CAPITAL, LLC | 1,836,000 | $104,303,000 | 1.77% |
Soleus Capital Management, L.P. | 182,400 | $10,362,000 | 1.62% |
Portland Global Advisors LLC | 62,635 | $3,558,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 40,000 | $2,263,000 | 0.55% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $113,336,000 | 0.53% |
Yorktown Management & Research Co Inc | 10,400 | $591,000 | 0.44% |
Hennion & Walsh Asset Management, Inc. | 120,240 | $6,831,000 | 0.36% |
Virtus ETF Advisers LLC | 9,599 | $545,000 | 0.24% |